Ultraviolet light triggers the conversion of Cu2+-bound Aβ42 aggregates into cytotoxic species in a copper chelation-independent manner.

about

Ultraviolet light triggers the conversion of Cu2+-bound Aβ42 aggregates into cytotoxic species in a copper chelation-independent manner.

Item

http://www.wikidata.org/entity/Q38836859

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Ultraviolet light triggers the ...... chelation-independent manner.

@en

type

Item

label

Ultraviolet light triggers the ...... chelation-independent manner.

@en

prefLabel

Ultraviolet light triggers the ...... chelation-independent manner.

@en

P1476

Ultraviolet light triggers the ...... chelation-independent manner.

@en

P2093

Changlin Liu

http://www.w3.org/2001/XMLSchema#string

Dan Zhang

http://www.w3.org/2001/XMLSchema#string

Dan Zhao

http://www.w3.org/2001/XMLSchema#string

Xiongwei Dong

http://www.w3.org/2001/XMLSchema#string

Yan Meng

http://www.w3.org/2001/XMLSchema#string

Yaojing Liu

http://www.w3.org/2001/XMLSchema#string

Yong Zhang

http://www.w3.org/2001/XMLSchema#string

Zhe Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio

A partially folded structure of amyloid-beta(1-40) in an aqueous environment

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Molecular and cellular approaches for diversifying and extending optogenetics

Spin-trapping and human neutrophils. Limits of detection of hydroxyl radical

A specific amyloid-beta protein assembly in the brain impairs memory

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

A prochelator activated by beta-secretase inhibits Abeta aggregation and suppresses copper-induced reactive oxygen species formation.

Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease.

Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease.

P2888

srep13897

P304

13897

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP13897

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281636271

http://www.w3.org/2001/XMLSchema#string

P6179

1010602603

http://www.w3.org/2001/XMLSchema#string

P698

26350232

http://www.w3.org/2001/XMLSchema#string

P932

4563556

http://www.w3.org/2001/XMLSchema#string